Oxaliplatin

CHEMBL414804 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
397.3 g/mol
LogP
Phase
4

A platinum-based chemotherapy drug binding to DNA to prevent cancer cell replication in colorectal cancer.

Khối lượng phân tử

397,2900 g/mol

TPSA

76,60 Ų

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]

InChI

InChI=1S/C6H12N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-8H,1-4H2;(H,3,4)(H,5,6);/q-2;;+2/t5-,6-;;/m1../s1

Molecular Formula

C8H14N2O4Pt

HBD / HBA

4 / 6

Liên kết có thể quay

0

Nguyên tử nặng

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A platinum-based chemotherapy drug binding to DNA to prevent cancer cell replication in colorectal cancer.

Yes, Oxaliplatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL414804. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9887053. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.